CN Patent

CN102089305A — 治疗用取代的1,7-联苯-1,2,3,5,6,7-六氢吡啶并[3,2,1-ij]喹啉化合物

Assigned to Allergan Inc · Expires 2011-06-08 · 15y expired

What this patent protects

本文公开的是由结构式(I)代表的化合物。还公开了与之相关的治疗方法、组合物和药物。

USPTO Abstract

本文公开的是由结构式(I)代表的化合物。还公开了与之相关的治疗方法、组合物和药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN102089305A
Jurisdiction
CN
Classification
—
Expires
2011-06-08
Drug substance claim
No
Drug product claim
No
Assignee
Allergan Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.